PFE (Pfizer) How high will it go? | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
PFE (Pfizer) How high will it go?

An SI Board Since June 1996

Posts	SubjectMarks	Bans	Symbol
9523	158	0	PFE

Emcee: Lynn	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
8823	Excerpt: In a research note published yesterday, the analyst mentions that the c	Qualified Opinion	-	9/9/2005
8822	Whoa. <i>As a result, we could see a slow uptake curve that is primarily	keokalani'nui	-	9/9/2005
8821	Yes, understood that it was NKTR. Thanks for the PFE stuff too. Regards, Dew	DewDiligence_on_SI	-	9/9/2005
8820	More research DB Meeting played out as expected. Approvable in oct with late	Robohogs	-	9/9/2005
8819	Morgan stanley made similar comments on NKTR. they reccommended to sell on appr	deeno	-	9/9/2005
8818	PFE reading Oppenheimer says should allow stock to move toward 30 over time alt	Robohogs	-	9/9/2005
8817	I gave you Nektar. Sorry! Do you want PFE? Jon	Robohogs	-	9/9/2005
8816	Thanks!	DewDiligence_on_SI	-	9/9/2005
8815	Most others raised target into high 20s or lower 30s. Includes Hambrecht fro	Robohogs	-	9/9/2005
8814	I only have access to ML, unfortunately.	tom pope	-	9/9/2005
8813	Thanks for posting that. Are other analysts similarly bearish? The comment abou	DewDiligence_on_SI	-	9/9/2005
8812	Actually, Rob, I don't give a s**t what you follow.	tom pope	-	9/9/2005
8811	I don't follow ML. - eom	Qualified Opinion	-	9/9/2005
8810	Merrill: Highlights PANEL DISCUSSION SUGGESTS COMMERCIAL CHALLENGES FOR EXUBERA	tom pope	-	9/9/2005
8809	The next few trading days should be interesting for PFE.	Brander	-	9/8/2005
8808	Good work by PFE—the data were wanting the first time around but they kept it. E	DewDiligence_on_SI	-	9/8/2005
8807	Pfizer plans Exubera monitoring programme Thu Sep 8, 2005 2:06 PM BST By Ben	Qualified Opinion	-	9/8/2005
8806	FDA Advisory Committee Recommends Approval of Exubera(R) for Use in Adults With	Qualified Opinion	-	9/8/2005
8805	On September 8, 2005, the committee will discuss new drug application (NDA) 21-8	Qualified Opinion	-	9/6/2005
8804	Delete	Qualified Opinion	-	8/31/2005
8803	Excerpt : The study was funded by Genentech Inc., which does not currently make	Qualified Opinion	-	8/31/2005
8802	Those given statin drugs before hospitalization and within 24 hours after a hear	Stephen O	-	8/30/2005
8801	Statin drugs lower heart attack death-study WASHINGTON (Reuters) - Giving a hea	Qualified Opinion	-	8/30/2005
8800	Anybody expect higher drug prices in the industry due to increased risk exposure	Qualified Opinion	-	8/19/2005
8799	Settlements of patent disputes are common. Look at the Barr Labs/Kos settlement	rkrw	-	8/5/2005

Go to reply# or date (mm/dd/yy):